Neurent Medical
5 known investors
Find your way into Neurent Medical
Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients. The company focuses on advancing neuromodulation technology to provide durable symptom relief and improve respiratory health outcomes.
Investors · 5
Funding
SEC filings, press & company announcements$135M disclosed across 2 rounds · 2026
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Neurent Medical do?
- Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients. The company focuses on advancing neuromodulation technology to provide durable symptom relief and improve respiratory health outcomes.
- Who are Neurent Medical's investors?
- Neurent Medical's investors include Atlantic Bridge Ventures, Enterprise Ireland, EQT Life Sciences, Fountain Healthcare Partners, Western Development Commission.
- How much funding has Neurent Medical raised?
- Neurent Medical has disclosed $135M raised across 2 rounds.